A recent addition to Labcorp’s service portfolio, NanoString’s nCounter® Analysis System and the GeoMx® Digital Spatial Profiler (DSP) can be used to inform how a drug modulates gene expression and the signaling pathways that regulate tumor growth.
The NanoString nCounter® allows for analysis of up to 800 RNA, DNA or protein targets simultaneously with high sensitivity and precision. The system utilizes molecular “barcodes” and single molecule imaging to quantitate hundreds of unique transcripts in a single sample.
Other key advantages of using the NanoString nCounter® include:
- A number of “off-the-shelf panels” for oncology (human and mouse) available, customizable to include up to 55 additional unique targets
- Optimized for challenging sample types (FFPE, tissue, lysates and biofluids)
- Only low amounts of precious sample material required
- Accurate and faster than qPCR (no amplification requirements) and simpler than next generation sequencing
While NanoString nCounter® provides great quantitative data on gene or protein expression levels from tumor samples, spatial context is key to gaining further insights into tissue biology. NanoString GeoMx® DSP is the spatial biology solution and it can be used to gain a deeper understanding of the tumor and the complex interactions within the tumor microenvironment.
In addition to being utilized as a standalone in vitro service for genetic expression screening using cell-based models, NanoString may also be used in an ex vivo setting to analyze the drug mechanism of action in in vivo animal models, thereby offering the ability to screen multiple therapeutics to identify promising lead compounds.